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Abstract Objectives To study clinical, imaging features and treatment outcomes of congenital cholesteatoma
of middle ear (CCME). Methods This is a retrospective review of 10 CCME cases selected from 952 cholesteato-
ma cases treated between January 1995 and December 2005 at the Department of Otolaryngology-Head and Neck
Surgery, Chinese PLA General Hospital. The main outcome measures were the site of origin, clinical features, sur-
gical findings, imaging characteristics and hearing results. Results The mean age of the 10 patients was 16
years(ranged from 10 to 24 years), with 6 being older than 18 years. There were 7 males and 3 females. The aver-
age delay to diagnosis was longer than 2 years. The mean preoperative PTA was 55 dB HL, with a mean ABG of
45 dB. Typical cholesteatomas were seen behind the tympanic membrane in the superoposterior quadrant on otos-
copy only in 2 patients. High resolution CT was completed in all patients. Most of the patients(8/10) were diag-
nosed with otosclerosis or ossicular abnormality before operation. All patients underwent a one-stage tympanoplas-
ty following transmeatal explorative tympanotomy and complete cholesteatoma removal, except one, who under-
went a CWU mastoidectomy due to extensive cholesteatoma involvement. The choleasteatoma lesion was con-
fined to the superoposterior mesotympanum in all patients. The mean postoperative PTA was 20 dB HL. All pa-
tients were followed-up for at least 1.5 years postoperatively. Revision procedures were performed in 2 patients for
hearing deterioration. No residual or recurrence of cholesteatoma was found. Conclusion CCME is a rare disease
that often gets delayed diagnosis. Residual lesions and the prognosis mainly depend on the extent of the lesion.
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Introduction
Congenital cholesteatoma of middle ear (CCME)
is a rare pathology that can go undiagnosed for years.
This article reports 10 cases of CCME focusing on
lesion location, clinical presentation, peri-operative
evaluations, surgical techniques, and outcomes.
Patients and methods
The 10 CCME cases were identified among 952
cholesteatoma cases treated between January 1995 and
December 2005 at the Department of
Otolaryngology-Head and Neck Surgery, Chinese PLA
General Hospital. The cases were identified based
upon modified criteria of Levenson et al., i.e. 1) no
history of otorrhea, tympanic membrane perforation, or
otologic procedures; 2) normal tympanic membrane on
otoscopy; and/or 3) a pearly white mass medial to the
tympanic membrane.
Each patient underwent thorough examination of
the ear, nose and throat. Hearing was assessed using a
pure tone audiometry(GSI61, Madsen, Denmark)
before and after the operation. Hearing outcomes were
determined using mean residual air-bone gap, based on
the difference between air and the bone conduction
thresholds at 250, 500, 1000, 2000, 4000 and 8000 Hz.
Other assessments included impedance tympanometry
(GSI33 version 2 Middle ear analyzer, Granson-Stadler
Inc., USA), ABR(Nicolet-Bravo, Nicolet Biomedical,
USA) and High-resolution computed tomography
(HRCT) scanning.
Surgical approaches were selected based upon CT
findings, hearing test results, location of the cholestea-
toma and integrity of the ossicular chain. Surgical pro-
cedures started with transmeatal exploratory tympanot-
omy in all 10 patients. Following removal of the le-
sion, the integrity of the ossicular chain was examined
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and ossiculoplasty was performed with PORT(type II),
TORP(type III) or allogenetic/autogenous ossicles
grafts, as appropriate.
Results
The mean patient age was 16 years (ranging from
10 to 24 years), with 6 being older than 18 years. There
were 7 males and 3 females(2.3:1). Average disease
duration before diagnosis was 2 year or longer in more
than half of the cases. The right ear was involved in 4
cases and left ear in 5 cases. Bilateral involvement was
seen in 1 patient.
Most patients had no ear complaints other than
hearing loss(10/10) and tinnitus(2/10) at the time of
presentation. There were no intracranial complications,
vertigo or facial paralysis. The tympanic membrane
appeared normal in 8 patients and signs indicative of
cholesteatoma were visible on otoscopy in 2 patients
(Fig.1).
The mean pre-operative PTA was 55 dB HL, with
a mean air-bone gap of 45 dB(Fig. 2). Type“A”
tympanograms were seen in 7 cases and type“Ad”in 2
cases. Absolute wave I latencies on ABR were
prolonged in all cases, consistent with conductive
hearing loss.
HRCT scans were completed in all 10 patients.
Lesions were characterized by a homogeneous mass of
soft-tissue density in the middle ear space, similar to
that of an acquired cholesteatoma except that the lesion
was mainly limited to posterior mesotympanum(Fig.
3). Eight of these lesions were predominantly confined
in the middle ear space. The rest two showed
infiltration in the antrum and epitympanum. The
mastoid remained pneumatic in most of these cases.
Otosclerosis or ossicular malformation was the
working diagnosis in 8 cases before surgery. A definite
diagnosis of cholesteatoma was established following
explorative tympanotomy in all cases.
One-stage close typanoplasty was performed in 9
cases following explorative tympanotomy and
complete cholesteatoma removal. CWU
mastoidectomy was the choice in one case due to
extensive cholesteatoma involvement.
Epitympanum and antrum involvement was
uncommon in this series. Lesion extension into the
attic below the ossicles was seen in only 2 cases and
the origin could not be determined. In the rest cases, a
well-encapsulated cystic lesion limited to the posterior
mesotympanum was typically seen. These lesions
seemed to arise from the middle ear, especially the
Fig 1. Otoscopic view of the CMCC in case 1. The cholestea-
toma is located in posteriosuperior mesotympanum and seen
behind tympanum.
Fig 2. Before and after operation audiograms in case 10.
The post-operative air-bone gap is reduced to 30 dB (red
line) from 53 dB before operation (blue line)
Fig 3. High resolution CT scan of CCME in a 24 years old man
with conductive hearing deficit (case 10). (3a) Axial section showing
abnormal soft-tissue debris in posterior mesotympanum (arrow).
(3b) Axial section showing implanted Teflon artificial stapes and no
residual or recurrence of disease at 1 year after surgery.
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Table 1．Patients Data
Patient
1
2
3
4
5
6
7
8
9
10
Age(y)
10
14
15
18
19
19
20
20
22
24
Gender
M
F
M
F
M
M
M
F
M
M
Ear
R
B
L
L
R
L
R
L
L
R
Type
Closed
Open
Closed
Closed
Closed
Open
Closed
Closed
Closed
Closed
Site
Post/superior
Unclear
Post/superior
Post/superior
Post/superior
Unclear
Post/superior
Post/superior
Post/superior
Post/superior
Preoperative
PTA(dB HL)
53
43
55
40
70
60
48
60
50
70
CT Finding
Normal
Normal
incus erosion, mass inside
ossicular
Small density at lateral canal
Mass in posterior and superior
tympanum
Normal mastoid, small density
at IS joint
Mass in mesotympanum
and atic
Soft-tissue in posterior
mesotympanum
Ossicular erosion,
Soft-tissue in posterior
mesotympanum
Procedure Performed
Ossiculoplasty TypeⅢ
(TORP)
Ossiculoplasty TypeⅢ
( autogenous incus)
Ossiculoplasty TypeⅢ
(TORP)
Ossiculoplasty TypeⅢ(TORP)
Ossiculoplasty TypeⅢ
(TORP)
Ossiculoplasty TypeⅢ
(PORP)
Ossiculoplasty TypeⅢ
(TORP)
CWU with Ossiculoplasty
TypeⅢ
(allogenetic malleus)
Ossiculoplasty TypeⅢ
(TORP)
Ossiculoplasty
(artificial stapes)
R: Right, L: Left, B: Bilaterl
incostapedial joints. Middle ear mucosa was nearly
normal in 7 cases, and the Eustachian tube was normal
in all the cases. The incus(10/10) and stapes (8/10)
were often eroded, especially at the incostapedial
joints, whereas the handle of the malleus was involved
in only 2 cases. Exposure of the facial nerve was seen
in 2 cases. Lateral semicircular canal erosion was seen
in 1 patient.
All patients underwent ossicular chain reconstruc-
tion. Materials used for ossicular reconstruction includ-
ed PORT (type II, n = 1), TORP (type III, n = 6), autog-
enous incus(type III, n = 1), allogenetic malleus (type
III, n = 1), and artificial stapes (n = 1) (Table 1).
All patients were followed-up postoperatively for
at least 1.5 years with an interval of 12～24 months.
The postoperative air-bone gap was 20 dB or less. The
middle ear was revisited in 2 patients at 1 and 6 years
in face of continuous hearing decline. No residual or
recurrence of disease was found on high resolution CT
scans or during second-look operation in these 2 cases.
The causes of hearing loss were polyps and ossicular
prosthesis dislocation.
Discussion
Temporal bone histopathologic studies have
demonstrated two distinct types of congenital
cholesteatoma[1]. One type appears to be cystic and
localized of anterior mesotympanum, in which
ossicular lesions are uncommon. These cholesteatomas
are most commonly documented and diagnosed in very
young children(mean age, 4years) at a systematic
evaluation, and can be removed easily. Hearing loss is
usually minimal(< 20 dB HL)[2]. The other type is of a
more diffuse, open form, in which cholesteatoma
matrix forms part of the middle ear mucosa. It most
often invades the superoposterior tympanum but
progressively concerns the epitympanum and the
posterior tympanic cavity. The ossicular chain is often
eroded, mainly at incustapedial joints, inducing a
consistent conductive deafness that leads to diagnosis
in older children (over age 5) and adults［3］. Hearing
loss is often more severe (>30 dB HL)［4］.
CCME is thought to be a rare condition in the clin-
ic, but the incidence(4% to 24%) is probably underesti-
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mated, because the diagnosis is usually made only
when the tympanic membrane has been perforated by
the progressively growing cholesteatoma. Of the 952
cholesteatoma cases diagnosed in the authors’prac-
tice, only 10 are congenital. Although the presentation
of some other cases may suggest a congenital origin,
they do not meet the Levenson et al criteria［5］.
In this series, the most common site of cholesteato-
ma was in the posterior mesotympanum around the in-
costapedial joint and no involvement of the anterior
tympanum was found. This is different from those re-
ported by Levenson et al ［5］ and Cohen［6］, but consis-
tent with findings by Karmarkar et al［7］．
Regardless of the embryological origin, which
may differ in individual cases, the so-called congenital
cholesteatoma has to meet the very strict criteria de-
fined by Derlacki and Clemis［8］ in 1965 and revised by
Levenson et al［5］. Many believe that these cholesteato-
mas behave in a more aggressive manner than does ac-
quired cholesteatoma. This opinion is in general based
on the frequent finding of more extensive invasion in a
normally pneumatized temporal bone, ossicular ero-
sion, and labyrinthine lesions at initial surgery.
In the clinic, the diagnosis of CMCC is often de-
layed for years. This is especially true for those origi-
nating from the posterior mesotympanum, whose pro-
gression is gradual and silent, with hearing loss being
the only symptom, which is often compensated by the
normal ear. All cholesteatomas in the present study
arose from the posterior mesotympanum with no symp-
toms during the early stage of mesotympanum involve-
ment. The patients did not seek medical attention until
the interruption of the ossicular chain that resulted in
notable hearing loss. In this group, the average delay in
diagnosis was more than 2 year, longer than 4 year in
half of the patients with the longest being 13 years.
In contrast to CCME in the posterior tympanum,
those originating from the superoanterior quadrant of
the middle ear tend to affect function of the Eustachian
tube, leading to pseudo－ otitis media with effusion.
Early diagnosis is made when myringotomy is per-
formed in these cases.
Clinical presentation of CMCC includes
impaired hearing, tinnitus, facial palsy, ear discharge
and vertigo. Some cases are incidentally diagnosed.
The main complaints in our series were deafness(10/
10) and tinnitus (2/10), with no facial palsy. Hearing
loss was conductive in all the cases. Hearing loss was
progressive in 3 cases, stable in 7 cases and incidental
findings in 5 cases. In 2 cases, hearing loss was noticed
after head shaking or trauma.
The association of congenital cholesteatomas with
other malformations is well documented, occurring in
almost 15% of patients［9-10］. In this study, congenital
cholesteatomas associated with malformation of the au-
ricle、external auditory canal or middle ear are not in-
cluded. The incidence of ossicular malformations is
higher in some series(25% to 33% ) than others［11-12］,
and seems higher than that of the general population,
suggesting a genetic factor in congenital cholesteatoma
［1］.
In treating CCME, a planned second look opera-
tion is not advocated［1, 13］. Most prefer to follow pa-
tients clinically and radiologically with HRCT scans,
performing a second surgical procedure only in cases
of functional failure or suspicion of relapse［2］. A 12 to
18 month period is the commonly reported interval for
follow-up, but some have recommended a shorter inter-
val(8- to 12-month) because of the particular aggres-
siveness of this disease and the need for functional re-
habilitation. We performed second look procedures in
2 of our cases at 1 and 6 years after surgery, because of
continuing hearing decline. No cholesteatoma recur-
rence was found and the causes of hearing loss in these
2 cases were polyps and prosthesis dislocation.
The rate of residual lesions and the prognosis in
CCME are mainly dependent on the initial extension of
the lesion. Rosenfeld et al［14］ suggest that residual le-
sions in CCME are not less common than in acquired
cholesteatoma, and they do not consider congenital
cholesteatomas to have a better prognosis than ac-
quired cholesteatomas. When a congenital cholesteato-
ma is cystic and limited, the risk of residual lesion is
low, but the risk can range from 20% to 52% for those
with extensive invasion［1, 15］.
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